TapewireFind a company

person · Reporting owner

RICKS THOMAS G

Disclosed activity across 4 companies

Tapewire entity
44380
SEC CIK
0001013023

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ENCANA CORPECA · Entity 153444DirectorNovember 01, 2019November 01, 2019
Faeth Therapeutics, Inc.SNSE · Entity 5029DirectorMay 21, 2025May 23, 2025
Ovintiv Inc.OVV · Entity 3288DirectorMay 21, 2026May 26, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ENCANA CORP

Report date November 01, 2019 · Filed November 01, 2019

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common SharesSEC Table I · non-derivativeDirect258,657 Reported balance After 2019-11-01 transaction · row 1
1 source row

Row 1 · 2019-11-01 · Purchase · Acquired 62,500 · Balance 258,657

Faeth Therapeutics, Inc.

Report date May 21, 2025 · Filed May 23, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.32 · Expires 2035-05-20Direct19,000 Reported balance After 2025-05-21 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-05-21 · Grant · Acquired 19,000 · Balance 19,000

F1: The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or May 21, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or May 21, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.

Ovintiv Inc.

Report date May 21, 2026 · Filed May 26, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect103,842 Reported balance After 2026-05-21 transaction · row 1
1 source row

Row 1 · 2026-05-21 · Exercise / conversion · Acquired 3,510 · Balance 103,842

F3: Represents the settlement upon vesting of RSUs.

F4: RSUs convert into Ovintiv common stock on a one-for-one basis.

Restricted Share UnitSEC Table II · derivative / convertible security · Expires 2026-05-21Direct3,510 Reported balance After 2026-05-21 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-05-21 · Grant · Acquired 3,510 · Balance 3,510

F1: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Restricted Share UnitSEC Table II · derivative / convertible security · Expires 2026-05-21Direct0 Reported balance After 2026-05-21 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-05-21 · Exercise / conversion · Disposed 3,510 · Balance 0

F2: Each RSU is the economic equivalent of one share of Ovintiv common stock and yields dividend equivalent RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F2: Each RSU is the economic equivalent of one share of Ovintiv common stock and yields dividend equivalent RSUs.

F3: Represents the settlement upon vesting of RSUs.

F4: RSUs convert into Ovintiv common stock on a one-for-one basis.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

NEWFIELD EXPLORATION CO /DE/

Report date February 13, 2019 · Filed February 14, 2019

Section 16 reporting ended · disclosed 2019-02-14. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
common stockSEC Table I · non-derivativeDirect0 Ending reported balance After 2019-02-13 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2019-02-13 · Disposition to issuer · Disposed 66,447 · Balance 6,968

F1: On February 13, 2019, pursuant to the Agreement and Plan of Merger dated as of October 31, 2018 (Merger Agreement), by and among Encana Corporation (Encana), Neapolitan Merger Corp. (Merger Sub), and Newfield Exploration Company (Newfield), Merger Sub merged with and into Newfield (the Merger) with Newfield surviving the Merger as a wholly-owned subsidiary of Encana. Pursuant to the Merger Agreement, upon consummation of the transactions contemplated therein, each share of Newfield common stock issued and outstanding was converted into the right to receive 2.6719 Encana common shares.

Row 2 · 2019-02-13 · Disposition to issuer · Disposed 6,968 · Balance 0

F2: Pursuant to the Merger Agreement, upon consummation of the transactions contemplated therein, all outstanding Newfield restricted stock awards (RSAs) were cancelled and each holder of RSAs was entitled to receive, on a fully-vested basis for each such RSA, the merger consideration, as described in the Merger Agreement and in note (1) above. There was no purchase price.

Filing footnotes · ownership attribution and instrument terms

F1: On February 13, 2019, pursuant to the Agreement and Plan of Merger dated as of October 31, 2018 (Merger Agreement), by and among Encana Corporation (Encana), Neapolitan Merger Corp. (Merger Sub), and Newfield Exploration Company (Newfield), Merger Sub merged with and into Newfield (the Merger) with Newfield surviving the Merger as a wholly-owned subsidiary of Encana. Pursuant to the Merger Agreement, upon consummation of the transactions contemplated therein, each share of Newfield common stock issued and outstanding was converted into the right to receive 2.6719 Encana common shares.

F2: Pursuant to the Merger Agreement, upon consummation of the transactions contemplated therein, all outstanding Newfield restricted stock awards (RSAs) were cancelled and each holder of RSAs was entitled to receive, on a fully-vested basis for each such RSA, the merger consideration, as described in the Merger Agreement and in note (1) above. There was no purchase price.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 21, 2026 Filed May 26, 2026 21:20 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionRestricted Share Unit · Derivative 3,510 $0.00 $0.00
Disclosure

SEC source: 0001013023-26-000002 · ownership.xml · derivative · entry 3

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,510 shares

Expires 2026-05-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Ovintiv common stock and yields dividend equivalent RSUs.

Read SEC document
May 21, 2026 Filed May 26, 2026 21:20 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 3,510 $0.00 $0.00
Disclosure

SEC source: 0001013023-26-000002 · ownership.xml · derivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,510

Underlying: Common Stock · 3,510 shares

Expires 2026-05-21

F1 · derivative.exercise_price: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
May 21, 2026 Filed May 26, 2026 21:20 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionCommon Stock 3,510 Not disclosed Not disclosed
Disclosure

SEC source: 0001013023-26-000002 · ownership.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,842

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Represents the settlement upon vesting of RSUs.

F4 · price: RSUs convert into Ovintiv common stock on a one-for-one basis.

Read SEC document
December 05, 2025 Filed Dec 9, 2025 00:38 UTC Ovintiv Inc. OVV · Entity 3288 GiftCommon Stock 900 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311580 · ownership.xml · nonDerivative · entry 4

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Ricks Family Trust

Disclosed balance after: 92,669

F1 · shares: On December 5, 2025, the reporting person, transferred by gift 900 shares indirectly held to family members from the Family Trust.

Read SEC document
December 05, 2025 Filed Dec 9, 2025 00:38 UTC Ovintiv Inc. OVV · Entity 3288 GiftCommon Stock 900 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311580 · ownership.xml · nonDerivative · entry 3

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Ricks Family Trust

Disclosed balance after: 93,569

F1 · shares: On December 5, 2025, the reporting person, transferred by gift 900 shares indirectly held to family members from the Family Trust.

Read SEC document
December 05, 2025 Filed Dec 9, 2025 00:38 UTC Ovintiv Inc. OVV · Entity 3288 GiftCommon Stock 900 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311580 · ownership.xml · nonDerivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Ricks Family Trust

Disclosed balance after: 94,469

F1 · shares: On December 5, 2025, the reporting person, transferred by gift 900 shares indirectly held to family members from the Family Trust.

Read SEC document
December 05, 2025 Filed Dec 9, 2025 00:38 UTC Ovintiv Inc. OVV · Entity 3288 GiftCommon Stock 900 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-311580 · ownership.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Ricks Family Trust

Disclosed balance after: 95,369

F1 · shares: On December 5, 2025, the reporting person, transferred by gift 900 shares indirectly held to family members from the Family Trust.

Read SEC document
May 21, 2025 Filed May 23, 2025 20:30 UTC Faeth Therapeutics, Inc. SNSE · Entity 5029 GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $0.32 $0.00
Disclosure

SEC source: 0001415889-25-014484 · form4-05232025_040512.xml · derivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2035-05-20

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or May 21, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:54 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionRestricted Share Unit · Derivative 5,501 $0.00 $0.00
Disclosure

SEC source: 0001667731-25-000666 · ricks2025.xml · derivative · entry 3

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,501 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Ovintiv common stock and yields dividend equivalent RSUs.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:54 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 5,501 $0.00 $0.00
Disclosure

SEC source: 0001667731-25-000666 · ricks2025.xml · derivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,501

Underlying: Common Stock · 5,501 shares

Expires 2025-05-16

F1 · derivative.exercise_price: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:54 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionCommon Stock 5,501 Not disclosed Not disclosed
Disclosure

SEC source: 0001667731-25-000666 · ricks2025.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,332

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Represents the settlement upon vesting of RSUs.

F4 · price: RSUs convert into Ovintiv common stock on a one-for-one basis.

Read SEC document
June 11, 2024 Filed Jun 13, 2024 21:03 UTC Faeth Therapeutics, Inc. SNSE · Entity 5029 GrantStock Option (Right to Buy) · Derivative 19,000 $0.00 Strike: $0.71 $0.00
Disclosure

SEC source: 0001415889-24-016691 · form4-06132024_090627.xml · derivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,000

Underlying: Common Stock · 19,000 shares

Expires 2034-06-10

F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or June 11, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.

Read SEC document
May 17, 2024 Filed May 21, 2024 21:21 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionRestricted Share Unit · Derivative 4,213 $0.00 $0.00
Disclosure

SEC source: 0001667731-24-000253 · ricks52124.xml · derivative · entry 3

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,213 shares

Expires 2024-05-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Ovintiv common stock and yields dividend equivalent RSUs.

Read SEC document
May 17, 2024 Filed May 21, 2024 21:21 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 4,213 $0.00 $0.00
Disclosure

SEC source: 0001667731-24-000253 · ricks52124.xml · derivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,213

Underlying: Common Stock · 4,213 shares

Expires 2024-05-17

F1 · derivative.exercise_price: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
May 17, 2024 Filed May 21, 2024 21:21 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionCommon Stock 4,213 Not disclosed Not disclosed
Disclosure

SEC source: 0001667731-24-000253 · ricks52124.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,831

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Represents the settlement upon vesting of RSUs.

F4 · price: RSUs convert into Ovintiv common stock on a one-for-one basis.

Read SEC document
March 08, 2024 Filed Mar 12, 2024 21:09 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionRestricted Share Unit · Derivative 8,402 $0.00 $0.00
Disclosure

SEC source: 0001667731-24-000133 · ricksmargrant24.xml · derivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,402 shares

Expires 2024-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
March 08, 2024 Filed Mar 12, 2024 21:09 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionCommon Stock 8,402 Not disclosed Not disclosed
Disclosure

SEC source: 0001667731-24-000133 · ricksmargrant24.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,618

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents the settlement upon vesting of RSUs.

F3 · price: RSUs convert into Ovintiv common stock on a one-for-one basis.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 21:52 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 57 $0.00 $0.00
Disclosure

SEC source: 0001667731-24-000032 · ricksq42023.xml · derivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,402

Underlying: Common Stock · 57 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F2 · price: Dividend equivalent RSUs received in lieu of cash dividends for the fourth quarter of 2023.

F1 · derivative.exercise_date: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F1 · derivative.expiration_date: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
September 29, 2023 Filed Oct 2, 2023 22:27 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 50 $0.00 $0.00
Disclosure

SEC source: 0001667731-23-000411 · ricksq32023.xml · derivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,345

Underlying: Common Stock · 50 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F2 · price: Dividend equivalent RSUs received in lieu of cash dividends for the third quarter of 2023.

F1 · derivative.exercise_date: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F1 · derivative.expiration_date: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
July 10, 2023 Filed Jul 12, 2023 21:02 UTC Faeth Therapeutics, Inc. SNSE · Entity 5029 GrantStock Option (Right to Buy) · Derivative 14,550 $0.00 Strike: $1.22 $0.00
Disclosure

SEC source: 0001209191-23-042102 · doc4.xml · derivative · entry 3

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,550

Underlying: Common Stock · 14,550 shares

Expires 2033-07-09

F3 · derivative.exercise_date: The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or July 10, 2024, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.

Read SEC document
July 10, 2023 Filed Jul 12, 2023 21:02 UTC Faeth Therapeutics, Inc. SNSE · Entity 5029 GrantCommon Stock 4,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-042102 · doc4.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,932

F1 · shares: These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or July 10, 2024, subject to the Reporting Person's continuous service with the Issuer through such vesting date.

Read SEC document
June 30, 2023 Filed Jul 5, 2023 20:47 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 65 $0.00 $0.00
Disclosure

SEC source: 0001667731-23-000269 · ricksq22023.xml · derivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,295

Underlying: Common Stock · 65 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F2 · price: Dividend equivalent RSUs received in lieu of cash dividends for the second quarter of 2023.

F1 · derivative.exercise_date: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F1 · derivative.expiration_date: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
May 18, 2023 Filed May 18, 2023 23:16 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionRestricted Share Unit · Derivative 6,074 $0.00 $0.00
Disclosure

SEC source: 0001667731-23-000238 · ricks51823.xml · derivative · entry 3

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,230

Underlying: Common Stock · 6,074 shares

Expires 2023-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Ovintiv common stock and yields dividend equivalent RSUs.

Read SEC document
May 18, 2023 Filed May 18, 2023 23:16 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 6,074 $0.00 $0.00
Disclosure

SEC source: 0001667731-23-000238 · ricks51823.xml · derivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,304

Underlying: Common Stock · 6,074 shares

Expires 2023-05-18

F1 · derivative.exercise_price: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
May 18, 2023 Filed May 18, 2023 23:16 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionCommon Stock 6,074 Not disclosed Not disclosed
Disclosure

SEC source: 0001667731-23-000238 · ricks51823.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,216

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Represents the settlement upon vesting of RSUs.

F4 · price: RSUs convert into Ovintiv common stock on a one-for-one basis.

Read SEC document
March 31, 2023 Filed Apr 4, 2023 21:29 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 58 $0.00 $0.00
Disclosure

SEC source: 0001667731-23-000150 · ricksq1.xml · derivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,230

Underlying: Common Stock · 58 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F2 · price: Dividend equivalent RSUs received in lieu of cash dividends for the first quarter of 2023.

F1 · derivative.exercise_date: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F1 · derivative.expiration_date: Each Restricted Share Unit ("RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:15 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionRestricted Share Unit · Derivative 14,709 $0.00 $0.00
Disclosure

SEC source: 0001667731-23-000128 · ricksmarchgrant2023.xml · derivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,172

Underlying: Common Stock · 14,709 shares

Expires 2023-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Share Unit (each, "RSU"') is the economic equivalent of one share of Ovintiv Inc. ("Ovintiv") common stock and yields dividend equivalent RSUs.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 22:15 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionCommon Stock 14,709 Not disclosed Not disclosed
Disclosure

SEC source: 0001667731-23-000128 · ricksmarchgrant2023.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,142

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents the settlement upon vesting of RSUs.

F3 · price: RSUs convert into Ovintiv common stock on a one-for-one basis.

Read SEC document
December 30, 2022 Filed Jan 3, 2023 23:19 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 113 $0.00 $0.00
Disclosure

SEC source: 0001667731-23-000028 · s2022sept30ricks.xml · derivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,881

Underlying: Common Stock · 113 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (each, "RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F2 · price: Dividend equivalent RSUs received in lieu of cash dividends for the fourth quarter of 2022.

F1 · derivative.exercise_date: Each Restricted Share Unit (each, "RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F1 · derivative.expiration_date: Each Restricted Share Unit (each, "RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
October 12, 2022 Filed Feb 13, 2023 20:23 UTC Ovintiv Inc. OVV · Entity 3288 GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001667731-23-000093 · ricksform52823.xml · nonDerivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Ricks Family Trust

Disclosed balance after: 96,269

F1 · shares: On October 12, 2022, the reporting person, transferred by gift 10,000 shares indirectly held to each of his children from the Family Trust.

Read SEC document
October 12, 2022 Filed Feb 13, 2023 20:23 UTC Ovintiv Inc. OVV · Entity 3288 GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001667731-23-000093 · ricksform52823.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Ricks Family Trust

Disclosed balance after: 106,269

F1 · shares: On October 12, 2022, the reporting person, transferred by gift 10,000 shares indirectly held to each of his children from the Family Trust.

Read SEC document
September 30, 2022 Filed Oct 4, 2022 23:21 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 124 $0.00 $0.00
Disclosure

SEC source: 0001667731-22-000378 · s2022sept30ricks.xml · derivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,768

Underlying: Common Stock · 124 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (each, "RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F2 · price: Dividend equivalent RSUs received in lieu of cash dividends for the third quarter of 2022.

F1 · derivative.exercise_date: Each Restricted Share Unit (each, "RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F1 · derivative.expiration_date: Each Restricted Share Unit (each, "RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and yields dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 19:43 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 123 $0.00 $0.00
Disclosure

SEC source: 0001667731-22-000268 · s2022jul5ricksq2draft.xml · derivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,644

Underlying: Common Stock · 123 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (each, "RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and attracts dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F2 · price: Dividend equivalent RSUs received in lieu of cash dividends for the second quarter of 2022.

F1 · derivative.exercise_date: Each Restricted Share Unit (each, "RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and attracts dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F1 · derivative.expiration_date: Each Restricted Share Unit (each, "RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and attracts dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
June 10, 2022 Filed Jun 14, 2022 20:15 UTC Faeth Therapeutics, Inc. SNSE · Entity 5029 GrantStock Option (Right to Buy) · Derivative 14,550 $0.00 Strike: $2.05 $0.00
Disclosure

SEC source: 0001209191-22-036668 · doc4.xml · derivative · entry 3

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,550

Underlying: Common Stock · 14,550 shares

Expires 2032-06-09

F3 · derivative.exercise_date: The shares subject to the option vest and become exercisable in 12 equal monthly installments over a one year period such that the option is fully vested on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date; provided that the option will in any case be fully vested on the date of the Company's next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such vesting date.

Read SEC document
June 10, 2022 Filed Jun 14, 2022 20:15 UTC Faeth Therapeutics, Inc. SNSE · Entity 5029 GrantCommon Stock 4,466 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-036668 · doc4.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,466

F1 · shares: These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, or June 10, 2023, subject to the Reporting Person's continuous service with the Issuer through such vesting date.

Read SEC document
June 07, 2022 Filed Jun 8, 2022 18:07 UTC Ovintiv Inc. OVV · Entity 3288 SaleCommon Stock 19,231 $59.50 $1,144,244.50
Disclosure

SEC source: 0001667731-22-000238 · ricks22jun7.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Ricks Family Trust

Disclosed balance after: 116,269

F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and effective as of April 1, 2022.

Read SEC document
May 23, 2022 Filed May 24, 2022 15:24 UTC Ovintiv Inc. OVV · Entity 3288 SaleCommon Stock 10,000 $50.00 $500,000.00
Disclosure

SEC source: 0001667731-22-000222 · ricks22524.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Ricks Family Trust

Disclosed balance after: 135,500

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and effective as of April 1, 2022.

Read SEC document
May 18, 2022 Filed May 19, 2022 23:08 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionRestricted Share Unit · Derivative 4,499 $0.00 $0.00
Disclosure

SEC source: 0001667731-22-000218 · s2022may18ricks.xml · derivative · entry 3

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,521

Underlying: Common Stock · 4,499 shares

Expires 2022-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Ovintiv common stock and attracts dividend equivalent RSUs.

Read SEC document
May 18, 2022 Filed May 19, 2022 23:08 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 4,499 $0.00 $0.00
Disclosure

SEC source: 0001667731-22-000218 · s2022may18ricks.xml · derivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,020

Underlying: Common Stock · 4,499 shares

Expires 2022-05-18

F1 · derivative.exercise_price: Each Restricted Share Unit (each, "RSU"') is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and attracts dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
May 18, 2022 Filed May 19, 2022 23:08 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionCommon Stock 4,499 Not disclosed Not disclosed
Disclosure

SEC source: 0001667731-22-000218 · s2022may18ricks.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,433

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Represents the settlement upon vesting of RSUs.

F4 · price: RSUs convert into Ovintiv common stock on a one-for-one basis.

Read SEC document
April 18, 2022 Filed Apr 19, 2022 22:53 UTC Ovintiv Inc. OVV · Entity 3288 SaleCommon Stock 10,000 $53.73 $537,300.00
Disclosure

SEC source: 0001667731-22-000169 · ricksapril1922.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Ricks Family Trust

Disclosed balance after: 145,500

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and effective as of April 1, 2022.

Read SEC document
March 31, 2022 Filed Apr 6, 2022 21:45 UTC Ovintiv Inc. OVV · Entity 3288 GrantRestricted Share Unit · Derivative 82 $0.00 $0.00
Disclosure

SEC source: 0001667731-22-000144 · ricks442022.xml · derivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,521

Underlying: Common Stock · 82 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Share Unit (each, "RSU'') is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and attracts dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F2 · price: Dividend equivalent RSUs received in lieu of cash dividends for the first quarter of 2022.

F1 · derivative.exercise_date: Each Restricted Share Unit (each, "RSU'') is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and attracts dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

F1 · derivative.expiration_date: Each Restricted Share Unit (each, "RSU'') is the economic equivalent of one share of common stock of Ovintiv Inc. ("Ovintiv") and attracts dividend equivalent RSUs. Vesting and exercise will occur in accordance with the Omnibus Incentive Plan and the applicable grant agreement and on the same schedule as the underlying RSUs.

Read SEC document
March 31, 2022 Filed Apr 6, 2022 21:45 UTC Ovintiv Inc. OVV · Entity 3288 PurchaseCommon Stock 19 Not disclosed Not disclosed
Disclosure

SEC source: 0001667731-22-000144 · ricks442022.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,934

F3 · shares: Ovintiv common stock acquired through reinvested dividends for the first quarter of 2022.

F4 · price: The common stock was acquired at market prices on March 31, 2022 which ranged from US$53.65 to US$55.55 per common share.

Read SEC document
March 08, 2022 Filed Mar 9, 2022 23:12 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionRestricted Share Unit · Derivative 5,184 $0.00 $0.00
Disclosure

SEC source: 0001667731-22-000087 · ricks2022.xml · derivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,438

Underlying: Common Stock · 5,184 shares

Expires 2022-03-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Ovintiv common stock and attracts dividend equivalent RSUs.

F4 · balance_after: Includes 1,639 RSUs acquired through reinvested dividends that were not previously reported due to an inadvertent administrative oversight as follows: 692 RSUs on March 30, 2020; 188 RSUs on June 30, 2020; 217 RSUs on September 30, 2020; 124 RSUs on December 31, 2020; 106 RSUs on March 31, 2021; 82 RSUs on June 30, 2021; 115 RSUs on September 30, 2021; and 115 RSUs on December 31, 2021.

Read SEC document
March 08, 2022 Filed Mar 9, 2022 23:12 UTC Ovintiv Inc. OVV · Entity 3288 Exercise / conversionCommon Stock 5,184 Not disclosed Not disclosed
Disclosure

SEC source: 0001667731-22-000087 · ricks2022.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,915

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement upon vesting of Restricted Share Units ("RSUs")

F2 · price: RSUs convert into Ovintiv Inc. ("Ovintiv") common stock on a one-for-one basis

F5 · balance_after: Includes Ovintiv common stock acquired through reinvested dividends

Read SEC document
December 10, 2021 Filed Dec 13, 2021 21:15 UTC Faeth Therapeutics, Inc. SNSE · Entity 5029 PurchaseCommon Stock 20,000 $5.86 $117,200.00
Disclosure

SEC source: 0000899243-21-047890 · doc4.xml · nonDerivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 341,769

F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.755 to $5.9953, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set herein.

F3 · ownership.nature: These shares are held by the Ricks Family Trust. Thomas Ricks is a trustee of the Ricks Family Trust and accordingly may be deemed to have voting and dispositive power with respect to the shares held by Ricks Family Trust.

Read SEC document
December 09, 2021 Filed Dec 13, 2021 21:15 UTC Faeth Therapeutics, Inc. SNSE · Entity 5029 PurchaseCommon Stock 20,000 $6.62 $132,400.00
Disclosure

SEC source: 0000899243-21-047890 · doc4.xml · nonDerivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 321,769

F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.515 to $6.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set herein.

F3 · ownership.nature: These shares are held by the Ricks Family Trust. Thomas Ricks is a trustee of the Ricks Family Trust and accordingly may be deemed to have voting and dispositive power with respect to the shares held by Ricks Family Trust.

Read SEC document
February 26, 2021 Filed Mar 2, 2021 20:03 UTC Ovintiv Inc. OVV · Entity 3288 GrantRights (Director Restricted Stock Unit) · Derivative 7,892 $0.00 $0.00
Disclosure

SEC source: 0001667731-21-000109 · thomasricks03012021.xml · derivative · entry 1

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,204

Underlying: Common Stock · 7,892 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Director Restricted Stock Unit (each, "RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. and attracts dividend equivalent RSUs. The RSUs vest immediately and settle in cash or common stock on the earlier of retirement from the Board or three years from the grant date.

F1 · derivative.exercise_date: Each Director Restricted Stock Unit (each, "RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. and attracts dividend equivalent RSUs. The RSUs vest immediately and settle in cash or common stock on the earlier of retirement from the Board or three years from the grant date.

F1 · derivative.expiration_date: Each Director Restricted Stock Unit (each, "RSU") is the economic equivalent of one share of common stock of Ovintiv Inc. and attracts dividend equivalent RSUs. The RSUs vest immediately and settle in cash or common stock on the earlier of retirement from the Board or three years from the grant date.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 23:47 UTC Faeth Therapeutics, Inc. SNSE · Entity 5029 ConversionSeries BB Preferred Convertible Stock · Derivative 3,037,849 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-009414 · doc4.xml · derivative · entry 3

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 63,288 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each share of the Series AA Preferred Stock and Series BB Preferred Stock converted to 0.0208333 shares of the Issuer's common stock, effective immediately prior to the closing of the Issuer's initial public offering of its common stock. The Series AA Preferred Stock and Series BB Preferred Stock had no expiration date.

F2 · derivative.exercise_date: Each share of the Series AA Preferred Stock and Series BB Preferred Stock converted to 0.0208333 shares of the Issuer's common stock, effective immediately prior to the closing of the Issuer's initial public offering of its common stock. The Series AA Preferred Stock and Series BB Preferred Stock had no expiration date.

F2 · derivative.expiration_date: Each share of the Series AA Preferred Stock and Series BB Preferred Stock converted to 0.0208333 shares of the Issuer's common stock, effective immediately prior to the closing of the Issuer's initial public offering of its common stock. The Series AA Preferred Stock and Series BB Preferred Stock had no expiration date.

F3 · ownership.direct: These shares are held by the Ricks Family Trust. Thomas Ricks is a trustee of the Ricks Family Trust and accordingly may be deemed to have voting and dispositive power with respect to the shares held by Ricks Family Trust.

F3 · ownership.nature: These shares are held by the Ricks Family Trust. Thomas Ricks is a trustee of the Ricks Family Trust and accordingly may be deemed to have voting and dispositive power with respect to the shares held by Ricks Family Trust.

Read SEC document
February 08, 2021 Filed Feb 10, 2021 23:47 UTC Faeth Therapeutics, Inc. SNSE · Entity 5029 ConversionSeries AA Preferred Convertible Stock · Derivative 11,447,156 $0.00 $0.00
Disclosure

SEC source: 0001209191-21-009414 · doc4.xml · derivative · entry 2

RICKS THOMAS G · CIK 0001013023 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 238,481 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each share of the Series AA Preferred Stock and Series BB Preferred Stock converted to 0.0208333 shares of the Issuer's common stock, effective immediately prior to the closing of the Issuer's initial public offering of its common stock. The Series AA Preferred Stock and Series BB Preferred Stock had no expiration date.

F2 · derivative.exercise_date: Each share of the Series AA Preferred Stock and Series BB Preferred Stock converted to 0.0208333 shares of the Issuer's common stock, effective immediately prior to the closing of the Issuer's initial public offering of its common stock. The Series AA Preferred Stock and Series BB Preferred Stock had no expiration date.

F2 · derivative.expiration_date: Each share of the Series AA Preferred Stock and Series BB Preferred Stock converted to 0.0208333 shares of the Issuer's common stock, effective immediately prior to the closing of the Issuer's initial public offering of its common stock. The Series AA Preferred Stock and Series BB Preferred Stock had no expiration date.

F3 · ownership.direct: These shares are held by the Ricks Family Trust. Thomas Ricks is a trustee of the Ricks Family Trust and accordingly may be deemed to have voting and dispositive power with respect to the shares held by Ricks Family Trust.

F3 · ownership.nature: These shares are held by the Ricks Family Trust. Thomas Ricks is a trustee of the Ricks Family Trust and accordingly may be deemed to have voting and dispositive power with respect to the shares held by Ricks Family Trust.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.